ES8304539A1 - Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos. - Google Patents

Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos.

Info

Publication number
ES8304539A1
ES8304539A1 ES512897A ES512897A ES8304539A1 ES 8304539 A1 ES8304539 A1 ES 8304539A1 ES 512897 A ES512897 A ES 512897A ES 512897 A ES512897 A ES 512897A ES 8304539 A1 ES8304539 A1 ES 8304539A1
Authority
ES
Spain
Prior art keywords
azobis
salicylic acid
salicylic
dianionic
acid composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512897A
Other languages
English (en)
Other versions
ES512897A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES8304539A1 publication Critical patent/ES8304539A1/es
Publication of ES512897A0 publication Critical patent/ES512897A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPOSICIONES QUE TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS DEL INTESTINO EN MAMIFEROS. CONSISTE EN PONER EN CONTACTO LA FORMA DIANIONICA DEL ACIDO 5,5 -AZOBISSALICILICO CON UNA RESINA DE INTERCAMBIO ANIONICO NO ABSORBIBLE, NO DEGRADABLE Y FISIOLOGICAMENTE COMPATIBLE, TAL COMO POLIESTIRENO RETICULADO CON 2% DE DIVINILBENCENO Y FUNCIONALIZADO EN EL ANILLO BENCENICO CON UN RESIDUO DE METILENTRIALQUILAMONIO, QUE ES SUFICIENTEMENTE BASICA PARA DESPROTONIZAR ACIDO BENZOICO.
ES512897A 1981-06-08 1982-06-07 Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos. Granted ES512897A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/271,748 US4374932A (en) 1981-06-08 1981-06-08 5-ASA Drug delivery system

Publications (2)

Publication Number Publication Date
ES8304539A1 true ES8304539A1 (es) 1983-03-01
ES512897A0 ES512897A0 (es) 1983-03-01

Family

ID=23036907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512897A Granted ES512897A0 (es) 1981-06-08 1982-06-07 Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos.

Country Status (13)

Country Link
US (1) US4374932A (es)
EP (1) EP0066861B1 (es)
JP (1) JPS57212119A (es)
AU (1) AU8462282A (es)
CA (1) CA1200204A (es)
DE (1) DE3262768D1 (es)
DK (1) DK253782A (es)
ES (1) ES512897A0 (es)
IE (1) IE53518B1 (es)
NO (1) NO153396C (es)
NZ (1) NZ200882A (es)
PT (1) PT75021B (es)
ZA (1) ZA823980B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500432A (es) * 1980-03-20 1982-03-11
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
SE8405924L (sv) * 1984-11-23 1986-05-24 Pharmacia Ab Nya azoforeningar
EP0611306B1 (en) * 1991-11-08 1998-07-08 Somatogen, Inc. Hemoglobins as drug delivery agents
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DK1313697T3 (da) * 2000-08-29 2006-04-10 Nobex Corp Immunregulatoriske forbindelser, derivater deraf samt anvendelse deraf
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
EP1429728A1 (en) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Sustained release preparations
US7825106B2 (en) 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US7737133B2 (en) * 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
FR2986010A1 (fr) * 2012-01-19 2013-07-26 Biomerieux Sa Detection in vitro de microorganismes presentant une activite azoreductase
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CN108479727A (zh) * 2018-03-20 2018-09-04 中山大学惠州研究院 一种水杨酸改性的苯乙烯聚合物及其吸附回收工业废水中苯胺类组分的方法
CN117567337A (zh) * 2023-11-21 2024-02-20 中国药科大学 一种含硫的5-氨基水杨酸前药及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB408676A (en) * 1931-10-17 1934-04-16 Ig Farbenindustrie Ag The manufacture of symmetrically substituted azobenzene compounds
US2697059A (en) * 1951-01-22 1954-12-14 Edwin L Gustus Hydroxy aromatic carboxylate-resin adsorption composition
US2721827A (en) * 1952-08-29 1955-10-25 Edwin L Gustus Composition containing polyamine resin having adsorbed thereon an anion of para-aminosalicylic acid
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US3143465A (en) * 1961-06-19 1964-08-04 Wallace & Tiernan Inc Pharmaceutical preparations comprising phosphorus containing cation exchange resins having a basic drug adsorbed thereon; and treatment therewith
SE7905051L (sv) * 1979-06-11 1980-12-12 Pharmacia Ab Nya sulfonamider
SE8002322L (sv) * 1980-03-26 1981-09-27 Pharmacia Ab Medel for behandling av inflammatoriska tarmsjukdomar
DE3027013A1 (de) * 1980-07-17 1982-02-18 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln

Also Published As

Publication number Publication date
NO153396B (no) 1985-12-02
IE821361L (en) 1982-12-08
DE3262768D1 (de) 1985-05-02
CA1200204A (en) 1986-02-04
EP0066861B1 (en) 1985-03-27
ZA823980B (en) 1983-07-27
IE53518B1 (en) 1988-12-07
EP0066861A1 (en) 1982-12-15
NO821898L (no) 1982-12-09
PT75021A (en) 1982-07-01
JPS57212119A (en) 1982-12-27
US4374932A (en) 1983-02-22
NZ200882A (en) 1985-08-30
AU8462282A (en) 1982-12-16
DK253782A (da) 1982-12-09
ES512897A0 (es) 1983-03-01
NO153396C (no) 1986-03-12
PT75021B (en) 1984-01-04

Similar Documents

Publication Publication Date Title
ES8304539A1 (es) Procedimiento de obtencion de composiciones para el tratamiento de enfermedades intestinales en mamiferos.
PT73202B (en) Process for the preparation of immunoregulators dicetopiperazine compounds
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
JPS6485984A (en) Methylenephosphonoalkylphosphinates, medicinal composition and therapy for abnormal calcium and phosphate metabolism
IE813104L (en) Method and compounds for treating inflammatory bowel¹disease
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
BG102556A (en) Orally applied pharmaceutical composition with modified release containing 5-asa, and a method for the treatment of intestinal diseases
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
GB1506217A (en) Oral antilipemic composition
DE3571984D1 (en) New substituted benzimidazoles, a process for their preparation and their use for inhibiting gastric acid secretion
JPS552601A (en) Anti-tumor agent for non-injection use
IL65445A (en) E-4-(3,4,5-trimethoxyphenyl)-4-oxo-2-butenoic acid,its salts,their preparation and pharmaceutical compositions containing them
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
EP0285871A3 (en) Sustained release granulate without binding agent
PT84399A (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
AU570446B2 (en) Dipyridamole controlled release compositon
PT86531A (de) Neue carbonsaeurederivate verfahren zu ihrer herstellung sowie arzneimittel die diese verbindungen enthalten
ES8302623A1 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico".
ES8308317A1 (es) Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
ES8500898A1 (es) Procedimiento para preparar esteres de acidos benzosulfonicos substituidos.
DE3363450D1 (en) Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them
GB1298587A (en) Methods of contraception and contraceptive compositions
ES8401095A1 (es) Procedimiento para la preparacion de 11 -cloro-15-esteroides.
FR2366279A1 (fr) Acides 5-alkoxy-picoliniques, procede pour leur preparation et composition anti-hypertensive contenant des acides 5-alkoxy-picolinique